Organovo Holdings, Inc. (ONVO): Price and Financial Metrics


Organovo Holdings, Inc. (ONVO)

Today's Latest Price: $0.60 USD

0.02 (-2.58%)

Updated Jul 10 4:00pm

Add ONVO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

ONVO Stock Summary

  • For ONVO, its debt to operating expenses ratio is greater than that reported by just 0.34% of US equities we're observing.
  • ONVO's price/sales ratio is 35.91; that's higher than the P/S ratio of 95.14% of US stocks.
  • With a year-over-year growth in debt of -100%, Organovo Holdings Inc's debt growth rate surpasses merely 0% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Organovo Holdings Inc, a group of peers worth examining would be VRAY, REFR, EGHT, XENT, and VERI.
  • Visit ONVO's SEC page to see the company's official filings. To visit the company's web site, go to www.organovo.com.
ONVO Daily Price Range
ONVO 52-Week Price Range

ONVO Stock Price Chart Technical Analysis Charts


ONVO Price/Volume Stats

Current price $0.60 52-week high $0.93
Prev. close $0.62 52-week low $0.19
Day low $0.60 Volume 511,241
Day high $0.65 Avg. volume 1,086,866
50-day MA $0.59 Dividend yield N/A
200-day MA $0.42 Market Cap 78.86M

Organovo Holdings, Inc. (ONVO) Company Bio


Organovo Holdings, Inc. focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company was founded in 2007 and is based in San Diego, California.


ONVO Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ONVO Latest Social Stream


Loading social stream, please wait...

View Full ONVO Social Stream

Latest ONVO News From Around the Web

Below are the latest news stories about Organovo Holdings Inc that investors may wish to consider to help them evaluate ONVO as an investment opportunity.

Hedge Fund Sentiment Is Stagnant On Organovo Holdings Inc (ONVO)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]

Yahoo | June 10, 2020

Why Organovo Stock Continues to Drop

We’ve been writing about disruptive technologies like 3D bioprinting for the past seven years now, and one stock that always seems to be going nowhere fast is Organovo (ONVO). In order to understand why Organovo stock continues to drop, we need to start from the beginning. The Origins of Organovo The story begins in 2010 […]

Nanalyze | April 16, 2020

Edited Transcript of ONVO earnings conference call or presentation 9-Nov-17 10:00pm GMT

Q2 2018 Organovo Holdings Inc Earnings Call

Yahoo | April 8, 2020

The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Masimo Corporation (NASDAQ: MASI) * Seattle Genetics, Inc. (NASDAQ: SGEN) * Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)Down In The Dumps (Biotech Stocks Hitting 52-week Lows April 7) * Celcuity Inc (NASDAQ: CELC) * Curis, Inc. (NASDAQ: CRIS) * Helius Medical Technologies Inc (NASDAQ: HSDT) * Menlo Therapeutics Inc (NASDAQ: MNLO) * TherapeuticsMD Inc (NASDAQ: TXMD) * Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL)Stocks In Focus COVID-19 Test Sales to Lift GenMark's Q1 Results; Company Raises 2020 Guidance GenMark Diagnostics, Inc (NASDAQ: GNMK) announced preliminary first-qua...

Yahoo | April 8, 2020

BRIEF-Organovo Announces Termination Of Merger Agreement With Tarveda Therapeutics

Organovo Holdings Inc:

Reuters | April 7, 2020

Read More 'ONVO' Stories Here

ONVO Price Returns

1-mo 15.58%
3-mo N/A
6-mo 32.95%
1-year 16.57%
3-year -77.53%
5-year -84.46%
YTD 68.68%
2019 -62.95%
2018 -28.36%
2017 -60.47%
2016 36.14%
2015 -65.66%

Continue Researching ONVO

Here are a few links from around the web to help you further your research on Organovo Holdings Inc's stock as an investment opportunity:

Organovo Holdings Inc (ONVO) Stock Price | Nasdaq
Organovo Holdings Inc (ONVO) Stock Quote, History and News - Yahoo Finance
Organovo Holdings Inc (ONVO) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8922 seconds.